Does NYSTATIN Cause Bladder transitional cell carcinoma? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Bladder transitional cell carcinoma have been filed in association with NYSTATIN (Nystatin and Triamcinolone Acetonide). This represents 1.2% of all adverse event reports for NYSTATIN.
23
Reports of Bladder transitional cell carcinoma with NYSTATIN
1.2%
of all NYSTATIN reports
0
Deaths
23
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From NYSTATIN?
Of the 23 reports, 23 (100.0%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NYSTATIN. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does NYSTATIN Cause?
Drug ineffective (330)
Off label use (149)
Dyspnoea (148)
Candida infection (145)
Nausea (120)
Rash (120)
Drug hypersensitivity (102)
Cough (91)
Asthma (90)
Condition aggravated (90)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which NYSTATIN Alternatives Have Lower Bladder transitional cell carcinoma Risk?
NYSTATIN vs NYSTATIN\TRIAMCINOLONE ACETONIDE
NYSTATIN vs OBETICHOLIC ACID
NYSTATIN vs OBINUTUZUMAB
NYSTATIN vs OCELLA
NYSTATIN vs OCRELIZUMAB